Ophthalmology Doctors in Scranton, PA Accepting Medicare

10 Ophthalmology doctors found. Showing 1 - 10

Randall R Peairs, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 200 Mifflin Ave, Scranton, PA 18503 Phone: 570-342-3145    Fax: 570-344-1309

William H Kehrli, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 200 Mifflin Avenue, Scranton, PA 18503 Phone: 570-342-3145    Fax: 570-344-1309

Dr. Christopher Shannon Jordan, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 200 Mifflin Ave, Scranton, PA 18503 Phone: 570-342-3145    Fax: 570-344-1309

Thomas S Boland, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 200 Mifflin Ave, Scranton, PA 18503 Phone: 570-342-3145    Fax: 570-344-1309

Arthur J Jordan Jr., DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 200 Mifflin Avenue, Scranton, PA 18503 Phone: 570-342-3145    Fax: 570-344-1309

Dr. Steven Vale, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4 Meadow Ave, Scranton, PA 18505 Phone: 570-504-1530    Fax: 570-504-1533

Michael W Rosiecki, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1360 Wyoming Ave, Scranton, PA 18509 Phone: 570-961-2504    Fax: 570-347-6585

Joseph Giacometti, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 200 Mifflin Ave, Scranton, PA 18503 Phone: 570-342-3145    Fax: 610-687-8773

William J Jordan Jr., DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 200 Mifflin Ave, Scranton, PA 18503 Phone: 570-342-3145    Fax: 570-344-1309

Jerome W Jordan, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 200 Mifflin Ave, Scranton, PA 18503 Phone: 570-342-3145    Fax: 570-344-1309

News Archive

Melatonin viable alternative for REM sleep behavior disorder treatment

Clonazepam and melatonin appear to be equally effective for the treatment of rapid eye movement sleep behavior disorder symptoms, although melatonin may be better tolerated, a naturalistic clinical study shows.

Halozyme announces positive Phase 2 results of PEGPH20 drug for treating metastatic pancreatic cancer patients

Halozyme Therapeutics, Inc., a biotechnology company developing novel oncology and drug-delivery therapies, today announced interim findings from the ongoing phase 2 clinical study of its investigational new drug PEGPH20 for the potential treatment of patients with metastatic pancreatic cancer.

New vaccine technology decreases E. coli in beef cattle

Despite millions of dollars spent on food safety research over the last 10 years, ground beef recalls due to E. coli O157:H7 were higher in 2007 than in 2006, according to researchers from Kansas State University and West Texas A&M University. E. coli O157:H7 has been linked to foodborne illnesses in humans after consuming contaminated beef and produce.

BrightFocus Foundation honors 5 outstanding scientists in fields of macular degeneration, glaucoma

The BrightFocus Foundation today honored five outstanding scientists in the fields of macular degeneration and glaucoma, presenting them with named research awards at an event during the annual meeting of the Association for Research in Vision and Ophthalmology.

Study looks at effect of probiotic capsule intervention on metabolic health among women with GDM

In a study to be presented on Feb. 5 in an oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Diego, researchers will report on the effect of a probiotic capsule intervention on maternal metabolic parameters and pregnancy outcomes among women with gestational diabetes.

Read more Medical News

› Verified 5 days ago